Speak to us about your Covid-19 Innovation
Perfectus Biomed Group help companies to test their products and obtain regulatory and marketing data to support claims against COVID-19 Contact us for more infoWelcome to the
Perfectus Biomed Group
Perfectus Biomed Group are leaders in standard and customized microbiology testing services for a variety of sectors, including wound care, medical devices, infectious disease, cosmetics and personal care, disinfectants and biocides, and dentistry and oral care.
From laboratories in the UK and the US we support your outsourced microbiology including virology and bacteriology, regulatory submissions, product efficacy testing, research and development and claims substantiation.
Our UK facility is a GLP-compliant and UKAS accredited ISO 17025 contract testing laboratory and both laboratories hold ISO 9001 certification. We are governed by the MHRA, UKAS and BSI and perform testing that meets the multiple regulatory requirements for CA and CE marks, and the new MDR/PMS European regulations.
Please contact us if you would like further information.
Our website Privacy Notice can be found here.
BACTERIOLOGY
Offering standard and customized microbiology, including accredited biofilm test methods.
CELL BIOLOGY
Offering biocompatibility testing to support the biological evaluation of medical devices.
What our customers say
TESTING SERVICES Perfectus Biomed specializes in novel antimicrobial assays, performing customized, accredited biofilm methodologies and supporting clients through regulatory approval processes such as FDA 510(K) submissions, New Drug Applications (NDAs) and Pre IND applications. Our dedicated team, lead by PhD scientists, offer Research and Development projects, GLP compliant testing and ISO 17025 testing within a time efficient, client focused approach. Our expertise and knowledge are fundamental to the services we provide.
SERVICES
|
|
SECTORS
|
|
Lateral Flow Devices
The rapid development of the production of lateral flow devices (LFD) over the last two years has been transformative. In the wake of the 2020 global pandemic, regulatory bodies made rapid changes to the requirements for bringing a lateral flow device to market. In...
EN 12791, EN 1500 and EN 1499 – Regulatory Submission for Hand Disinfection Returns
H]Throughout the pandemic the burden of data required to take a hand wash product to market was significantly reduced. As we emerge from the last two years regulatory requirements are changing to again include safety testing, efficacy testing and the inclusion of a...
AMR and Biofilm – A Relationship We Must Acknowledge in Our Efforts to Fight AMR
AMR and Biofilm – What Does It Mean?
Antimicrobial resistance (AMR) is a global health threat referred to as the ‘silent pandemic’. The World Health Organisation (WHO) has declared that AMR is one of the top 10 global public health threats facing humanity,1 and it has...